Group 1: Fund Performance - iMGP Small Company Fund returned 1.33% in Q4 2025, underperforming the Russell 2000 Index which returned 2.19% [1] - The Fund's overall returns were flat at 0.01% for 2025, compared to a 12.81% return for the Index [1] - The Fund's poor performance in Q4 was attributed to the impressive performance of biotech businesses, which increased by over 25% [1] Group 2: Manhattan Associates, Inc. Overview - Manhattan Associates, Inc. (NASDAQ:MANH) specializes in software solutions for supply chains, inventory, and omni-channel operations [2] - As of March 09, 2026, Manhattan Associates' stock closed at $150.16 per share, with a one-month return of 0.35% and a 52-week loss of 10.36% [2] - The company has a market capitalization of $9.048 billion [2] Group 3: Performance Insights on Manhattan Associates, Inc. - Manhattan Associates underperformed in Q4 due to weaker-than-expected bookings in Q3, which interrupted momentum [3] - Weakness in the retail sector and poor market sentiment in software also negatively impacted the stock [3] - The market is seeking consistency to regain confidence in the stock following last year's disappointment and CEO transition [3] - There is growing conviction in Manhattan Associates' competitive position and growth opportunities, particularly with new CEO Eric Clark potentially improving growth [3]